American Oncology Network partners with Humana, Evolent to reduce cancer care prior authorizations
Bitget2026/11/10 17:19- American Oncology Network, Humana and Evolent launched a cancer care model across clinics in eight states to reduce reliance on prior authorization.
- Practices meeting quality and evidence-based treatment standards will no longer need traditional prior authorization for most anticancer drug therapies.
- The collaboration aims to improve treatment timeliness, quality and affordability through clinical pathways, quality improvement programs and provider performance reporting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EIA expects Brent crude spot prices to remain at $100 per barrel for the rest of the year and raises the average price forecasts for this year and next.
The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.
Moody’s and Chainlink Complete Cross-Chain Credit Ratings Distribution Pilot
Crypto prices
More
